Show simple item record

dc.contributor.advisorFlorance, Hannah
dc.contributor.authorEsswein, Stefan Theo
dc.date.accessioned2011-01-18T14:33:39Z
dc.date.available2011-01-18T14:33:39Z
dc.date.issued2010
dc.identifier.urihttp://hdl.handle.net/1842/4638
dc.description.abstractMass spectrometry is a versatile, sensitive and fast technique with which to probe biophysical properties in biological systems and one of the most important analytical tools in the multidisciplinary field of proteomics. The study of nativestate proteins and their complexes in the gas-phase is well established and direct infusion electrospray ionisation mass spectrometry (DI-ESI-MS) techniques are becoming increasingly popular as a tool for screening and determining quantitative information on protein-protein and protein-ligand interactions. However, complexes retained by ESI-MS are not always representative of those in solution and care must be taken in interpreting purely gas-phase results. This thesis details modification and advancement of solution phase techniques devised by Gross et al. utilising ESI-MS and Fitzgerald et al. applying matrix assisted laser desorption ionisation (MALDI)-MS termed PLIMSTEX (protein-ligand interactions by mass spectrometry, titration and hydrogen-deuterium-exchange)[1] and SUPREX (Stability of unpurified proteins from rates of H/D exchange)[2] to quantify these interactions with regards to high throughput analysis. The first part of this thesis describes the different developmental stages of the devised HPLC-front ends and their optimisation with myoglobin and insulin. The successfully developed HPLC-front end in conjunction with PLIMSTEX and SUPREX and ESI-MS then gets tested with self expressed and purified cyclophilin A(CypA)- cyclosporin A (CsA) system, followed by a test screen with potential CypA binding ligands. Dissociation constants (Kd’s) within one order of magnitude to reported values are determined. In the third part of this thesis the application of the devised ESI-SUPREX methodology has been applied to anterior gradient 2 (AGr2) and the factor H complement control proteins module 19-20 (fH19-20) exhibiting binding potential to a taggedhexapeptide and a synthetic pentasaccharide, respectively, resulting in thermodynamical data for these protein-ligand interactions. For the AGr2 system another dimension of investigation has been added by temperature controlling the devised ESI-SUPREX approach, revealing a phase transition in the protein at higher temperatures. The final part of this thesis describes the application of the ESI-SUPREX methodology to probe folding properties of CypA in the presence of the self expressed and purified E. coli chaperonin groEL. Thereby the denaturing properties of groEL have been emphasised along with the stabilisation of a denatured CypA species.en
dc.contributor.sponsorMarie Curie Research Training network (contract: MEST-CT-2005-020744)en
dc.contributor.sponsorUniversity of Edinburghen
dc.language.isoenen
dc.publisherThe University of Edinburghen
dc.relation.hasversionFerreira, V. P.; Herbert, A. P.; Cortes, C.; McKee, K. A.; Blaum, B. S.; Esswein, S. T.; Uhrin,D.; Barlow, P. N.; Pangburn, M. K.; Kavanagh, D., The binding of factor h to a complex of physiological polyanions and c3b on cells is impaired in atypical hemolytic uremic syndrome. J. Immunol. 2009, 182, 11, 7009–7018.en
dc.subjectmass spectrometryen
dc.subjectdirect infusion electrospray ionisation mass spectrometryen
dc.subjectDI-ESI-MSen
dc.subjectmatrix assisted laser desorption ionisationen
dc.subjectbinding potentialen
dc.subjecttagged hexapeptideen
dc.titleProbing protein-ligand interactions via solution phase hydrogen exchange mass spectrometryen
dc.typeThesis or Dissertationen
dc.type.qualificationlevelDoctoralen
dc.type.qualificationnamePhD Doctor of Philosophyen


Files in this item

This item appears in the following Collection(s)

Show simple item record